100% Cancer Remission Achieved in ALL Patients in Groundbreaking Study

Dr. Andrea Cercek, one of the lead researchers, said:

“It’s absolutely incredible … We’ve certainly never seen this before.”

All 12 patients experienced complete rectal cancer remission after receiving dostarlimab, a monoclonal antibody. This particular monoclonal antibody achieved 100% cancer remission without chemotherapy, radiation, surgery, or the toxic side effects that come with such therapies.

The authors wrote:

“All 12 patients (100%; 95% confidence interval) had a clinical complete response, with no evidence of tumor on magnetic resonance imaging … and no cases of progression or recurrence had been reported during follow-up (range, 6 to 25 months after treatment). No adverse events of grade 3 or higher have been reported.”

How does this monoclonal antibody actually work?

Dr. Andrea Cercek explained that it essentially unlocks the body’s ability to heal itself.

By Radiopatriot

A former talk radio host turned political activist, diving deep into the intricacies of political warfare and sharing insights on the shadow government and 5th Generation Psy-Ops. RadioPatriot's been diving into political intrigue, from FBI hearings to questioning staged events. Twitter.com/RadioPatriot * Telegram/Radiopatriot * Telegram/Andrea Shea King Gettr/radiopatriot * TRUTHsocial/Radiopatriot

1 comment

  1. The cure for cancer is not in the Medical industry/Big Pharma’s best $$ interest…….believe it’s been in place for a long time. Ivermectin has also been proven to cure cancer, and has been documented to do so via similar trials. The crimes against humanity are great.

Leave a Reply

Discover more from The Radio Patriot

Subscribe now to keep reading and get access to the full archive.

Continue reading